Insider · CIK 0001219016
Michael W Bonney
Files at ALNY (ALNYLAM PHARMACEUTICALS, INC.). First filing May 19, 2025, latest May 19, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALNY: ALNYLAM PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | ALNYLAM PHARMACEUTICALS, INC. | $3.1M 11,250 shares | -40% | +26% from low-6% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Common Stock10b5-1 | +11,250 | $131.21 | $1.5M | 28,054 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -549 | $267.14 | $147k | 27,505 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -729 | $268.56 | $196k | 26,776 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -245 | $269.79 | $66k | 26,531 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -431 | $271.68 | $117k | 26,100 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -660 | $273.16 | $180k | 25,440 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -882 | $273.75 | $241k | 24,558 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -301 | $275.63 | $83k | 24,257 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,263 | $277.16 | $350k | 22,994 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,239 | $278.01 | $344k | 21,755 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -432 | $280.03 | $121k | 21,323 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -372 | $281.10 | $105k | 20,951 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -802 | $282.03 | $226k | 20,149 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,728 | $282.81 | $489k | 18,421 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1,617 | $283.83 | $459k | 16,804 | May 19, 2025 |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -11,250 | $0.00 | $0 | 0 | May 19, 2025 |
| May 8, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock | +775 | $0.00 | $0 | 16,804 | May 12, 2025 |
| May 8, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +1,558 | $0.00 | $0 | 1,558 | May 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.